Imaging Genetics Study Based on a Temporal Group Sparse Regression and Additive Model for Biomarker Detection of Alzheimer's Disease

被引:21
作者
Huang, Meiyan [1 ,2 ]
Chen, Xiumei [1 ,2 ]
Yu, Yuwei [1 ,2 ]
Lai, Haoran [1 ,2 ]
Feng, Qianjin [1 ,2 ]
机构
[1] Southern Med Univ, Sch Biomed Engn, Guangzhou 510515, Peoples R China
[2] Southern Med Univ, Guangdong Prov Key Lab Med Image Proc, Guangzhou 510515, Peoples R China
基金
美国国家卫生研究院; 中国国家自然科学基金;
关键词
Genetics; Diseases; Biological system modeling; Data models; Brain modeling; Biomedical imaging; Additives; Imaging genetics; Alzheimer’ s disease; longitudinal imaging data; nonparametric regression model; magnetic resonance imaging; single nucleotide polymorphism; MILD COGNITIVE IMPAIRMENT; GENOME-WIDE ASSOCIATION; ATROPHY; CORTEX; POLYMORPHISMS; PHENOTYPES; PROGRESS; VOLUMES; GYRUS; LOBE;
D O I
10.1109/TMI.2021.3057660
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Imaging genetics is an effective tool used to detect potential biomarkers of Alzheimer's disease (AD) in imaging and genetic data. Most existing imaging genetics methods analyze the association between brain imaging quantitative traits (QTs) and genetic data [e.g., single nucleotide polymorphism (SNP)] by using a linear model, ignoring correlations between a set of QTs and SNP groups, and disregarding the varied associations between longitudinal imaging QTs and SNPs. To solve these problems, we propose a novel temporal group sparsity regression and additive model (T-GSRAM) to identify associations between longitudinal imaging QTs and SNPs for detection of potential AD biomarkers. We first construct a nonparametric regression model to analyze the nonlinear association between QTs and SNPs, which can accurately model the complex influence of SNPs on QTs. We then use longitudinal QTs to identify the trajectory of imaging genetic patterns over time. Moreover, the SNP information of group and individual levels are incorporated into the proposed method to boost the power of biomarker detection. Finally, we propose an efficient algorithm to solve the whole T-GSRAM model. We evaluated our method using simulation data and real data obtained from AD neuroimaging initiative. Experimental results show that our proposed method outperforms several state-of-the-art methods in terms of the receiver operating characteristic curves and area under the curve. Moreover, the detection of AD-related genes and QTs has been confirmed in previous studies, thereby further verifying the effectiveness of our approach and helping understand the genetic basis over time during disease progression.
引用
收藏
页码:1461 / 1473
页数:13
相关论文
共 70 条
[1]  
A. S. Disease, 2019, ALZHEIMERS DIS INT W
[2]   Thalamic pathology and memory loss in early Alzheimer's disease: moving the focus from the medial temporal lobe to Papez circuit [J].
Aggleton, John P. ;
Pralus, Agathe ;
Nelson, Andrew J. D. ;
Hornberger, Michael .
BRAIN, 2016, 139 :1877-1890
[3]  
[Anonymous], 2020, Alzheimer's disease facts and figures
[4]  
[Anonymous], 1998, NeuroImage
[5]   Comparisons of Multi-Marker Association Methods to Detect Association Between a Candidate Region and Disease [J].
Ballard, David H. ;
Cho, Judy ;
Zhao, Hongyu .
GENETIC EPIDEMIOLOGY, 2010, 34 (03) :201-212
[6]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[7]   Common Alzheimer's Disease Risk Variant within the CLU Gene Affects White Matter Microstructure in Young Adults [J].
Braskie, Meredith N. ;
Jahanshad, Neda ;
Stein, Jason L. ;
Barysheva, Marina ;
McMahon, Katie L. ;
de Zubicaray, Greig I. ;
Martin, Nicholas G. ;
Wright, Margaret J. ;
Ringman, John M. ;
Toga, Arthur W. ;
Thompson, Paul M. .
JOURNAL OF NEUROSCIENCE, 2011, 31 (18) :6764-6770
[8]   Robust multi-label transfer feature learning for early diagnosis of Alzheimer's disease [J].
Cheng, Bo ;
Liu, Mingxia ;
Zhang, Daoqiang ;
Shen, Dinggang .
BRAIN IMAGING AND BEHAVIOR, 2019, 13 (01) :138-153
[9]  
Chi EC, 2013, I S BIOMED IMAGING, P740
[10]  
Chui H., 1996, Alzheimer Disease Associated Disorders, V10, P53, DOI DOI 10.1097/00002093-199601010-00009